bf/NASDAQ:BIIB_icon.jpeg

NASDAQ:BIIB

Biogen Inc.

  • Stock

USD

Last Close

156.74

06/11 22:15

Market Cap

33.89B

Beta: 0.19

Volume Today

2.32M

Avg: 876.67K

PE Ratio

24.00

PFCF: 34.22

    Description

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing EN...Show More

    Earnings

    Earnings per Share (Estimate*)

    2468102017-07-252019-07-232021-07-222023-07-252024-10-30

    Revenue (Estimate*)

    1B2B3B4B2017-07-252019-07-232021-07-222023-07-252024-10-30

    *Estimate based on analyst consensus